Concourse Financial Group Securities’s Qualigen Therapeutics QLGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6362 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7023 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7019 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7032 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7031 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6961 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6798 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6637 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6399 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6408 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6230 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6179 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6063 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6028 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5854 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5662 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5478 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5330 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5125 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4993 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4958 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4896 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4702 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4834 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4768 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4655 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4422 |
|